150 related articles for article (PubMed ID: 15283323)
1. [Erythropoietin resistance as initial presentation of ANCA-positive intra-alveolar hemorrhage in a hemodialysis patient].
Sirvent AE; Arenas MD; Egea JJ; Gil MT
Nefrologia; 2004; 24(3):296-7. PubMed ID: 15283323
[No Abstract] [Full Text] [Related]
2. [Alveolar hemorrhage in pulmonary-renal syndrome anti-SCL/70 and anti-MPO-ANCA positive].
Defendenti C; Spina MF; Castiglione A; Atzeni F; Miadonna A; Saudelli M; Guercilena G; Sarzi-Puttini P
Recenti Prog Med; 2009; 100(7-8):361-4. PubMed ID: 19725477
[TBL] [Abstract][Full Text] [Related]
3. [Case of systemic sclerosis presenting with alveolar hemorrhage and positive anti-neutrophil cytoplasmic myeloperoxidase antibody(MPO-ANCA) without pathological renal involvement].
Yamada T; Nakajima H; Tanaka E; Nakajima A; Terai C; Hara M; Kamatani N
Ryumachi; 2003 Oct; 43(4):690-5. PubMed ID: 14598664
[TBL] [Abstract][Full Text] [Related]
4. [Recurrence of p-ANCA positive vasculitis with lung hemorrhage in a patient on hemodialysis].
Merino JL; Galeano C; Martins J; Pascual J; Teruel JL; Ortuño J
Nefrologia; 2008; 28(4):457-60. PubMed ID: 18662156
[TBL] [Abstract][Full Text] [Related]
5. [A hematocrit greater than 36 lessens mortality and hospitalization in hemodialysis].
Fernández-Gallego J; Gutiérrez C
Nefrologia; 2003; 23(2):177-8. PubMed ID: 12778885
[No Abstract] [Full Text] [Related]
6. Anti-Neutrophil Cytoplasmic Antibody (ANCA)-Negative Small Vessel Vasculitis: A Rare Cause of Pulmonary Renal Syndrome.
Munshi BD; Sengupta S; Sharan A; Mukhopadhyay S; Ghosh B; Dasgupta A; Bhattacharyya R
Intern Med; 2015; 54(21):2759-63. PubMed ID: 26521907
[TBL] [Abstract][Full Text] [Related]
7. Orally administrated Juzen-taiho-to/TJ-48 ameliorates erythropoietin (rHuEPO)-resistant anemia in patients on hemodialysis.
Nakamoto H; Mimura T; Honda N
Hemodial Int; 2008 Oct; 12 Suppl 2():S9-S14. PubMed ID: 18837771
[TBL] [Abstract][Full Text] [Related]
8. Hemoglobin levels, quality of life, and survival.
Sadler JH; Meyer KB
Nephrol News Issues; 2007 Aug; 21(9):42-3. PubMed ID: 17722853
[No Abstract] [Full Text] [Related]
9. An unusual etiology of erythropoietin resistance: hyperthyroidism.
Kaynar K; Ozkan G; Erem C; Gul S; Yilmaz M; Sonmez B; Ozdemir F; Ulusoy S
Ren Fail; 2007; 29(6):759-61. PubMed ID: 17763175
[TBL] [Abstract][Full Text] [Related]
10. Clinical features and outcome of pediatric Wegener's granulomatosis.
Akikusa JD; Schneider R; Harvey EA; Hebert D; Thorner PS; Laxer RM; Silverman ED
Arthritis Rheum; 2007 Jun; 57(5):837-44. PubMed ID: 17530684
[TBL] [Abstract][Full Text] [Related]
11. The continuous erythropoietin receptor activator (C.E.R.A.) corrects anemia at extended administration intervals in patients with chronic kidney disease not on dialysis: results of a phase II study.
Provenzano R; Besarab A; Macdougall IC; Ellison DH; Maxwell AP; Sulowicz W; Klinger M; Rutkowski B; Correa-Rotter R; Dougherty FC;
Clin Nephrol; 2007 May; 67(5):306-17. PubMed ID: 17542340
[TBL] [Abstract][Full Text] [Related]
12. [Intracranial hypertrophic pachymeningitis with high perinuclear anti-neutrophil cytoplasmic antibody (p-ANCA) occurred in a patient on hemodialysis].
Tajima Y; Miyazaki Y; Sudoh K; Matumoto A
Rinsho Shinkeigaku; 2002 Mar; 42(3):243-6. PubMed ID: 12474297
[TBL] [Abstract][Full Text] [Related]
13. Using online surveillance to monitor EPO dosing.
Fast S; Jobalia A; Ordway F; Luo F
Nephrol News Issues; 2011 Nov; 25(12):24-5. PubMed ID: 22204157
[No Abstract] [Full Text] [Related]
14. Splenic Infarcts and Pulmonary Renal Syndrome in a Young Patient with Double-Positive Anti-GBM and ANCA-Associated Vasculitis.
Rajah FT; Alhabobi AA; Aloudah NM; Osman AI; Elhassan EA
Saudi J Kidney Dis Transpl; 2021; 32(1):240-244. PubMed ID: 34145139
[TBL] [Abstract][Full Text] [Related]
15. [Treatment of renal anemia with intravenous erythropoietin in patients in the program of continuous ambulatory peritoneal dialysis].
Zelichowski G; Lubas A; Sienkiewicz M; Janusz E; Wańkowicz Z
Pol Merkur Lekarski; 2008 Apr; 24(142):312-5. PubMed ID: 18634362
[TBL] [Abstract][Full Text] [Related]
16. Clinical outcome of patients with coexistent antineutrophil cytoplasmic antibodies and antibodies against glomerular basement membrane.
Lindic J; Vizjak A; Ferluga D; Kovac D; Ales A; Kveder R; Ponikvar R; Bren A
Ther Apher Dial; 2009 Aug; 13(4):278-81. PubMed ID: 19695059
[TBL] [Abstract][Full Text] [Related]
17. Can acidosis and hyperphosphataemia result in increased erythropoietin dosing in haemodialysis patients?
Diskin CJ; Stokes TJ; Dansby LM; Radcliff L; Carter TB
Nephrology (Carlton); 2006 Oct; 11(5):394-9. PubMed ID: 17014551
[TBL] [Abstract][Full Text] [Related]
18. [Pure red cell aplasia in patients treated with recombinant erythropoietin for anemia due to chronic renal disease].
Miyazaki T; Obana T; Takasaki H; Tanaka M; Yamaji S; Fujimaki K; Fujita H; Kanamori H; Ishigatsubo Y
Rinsho Ketsueki; 2007 May; 48(5):391-6. PubMed ID: 17571584
[TBL] [Abstract][Full Text] [Related]
19. [Pathogenesis and compensation of renal anemia in children].
Müller-Wiefel DE
Fortschr Med; 1982 Oct; 100(38):1765-8. PubMed ID: 6216194
[No Abstract] [Full Text] [Related]
20. Intensity of hemodialysis and response to erythropoietin.
Kotanko P
N Engl J Med; 1996 Jun; 334(25):1670; author reply 1670-1. PubMed ID: 8628371
[No Abstract] [Full Text] [Related]
[Next] [New Search]
